NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2025
Voltar para busca
Dado oficial do USPTO
SYMBIOZE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
12/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
12/04/2022
Data de registro
27/02/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/02/2024
Última transação
12/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
FR
Examinador
WERT,KARL ANTHONY
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
N. V. (pessoa física)
Representantes
Andy I. Corea Murtha Cullina LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Injection devices for pharmaceutical preparations; injection pumps for pharmaceutical purposes; portable medical fluid injectors; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical apparatus for intravenous, intradermal, intramuscular or subcutaneous infusion, tissue infusion, injection and accessories thereof being patch-worn on-body injector, namely, a syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection intended to cooperate with a medical pump, all the foregoing being medical infusion and injection devices for administering drugs; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical adhesive apparatus for intravenous, intradermal, intramuscular or subcutaneous injection or infusion and replacement parts thereof being patch-worn on-body injector, namely, a syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection intended to cooperate with a medical pump, all the foregoing being medical infusion and injection devices for administering drugs; medical pumps for intravenous, intramuscular, intradermal or subcutaneous injection or infusion and replacement parts thereof, namely, reusable or disposable medical pump intended to cooperate with medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection, all the foregoing being medical infusion or injection devices and replacement parts thereof for administering drugs; patch pumps being adhesive infusion pumps for delivering measured injection of pharmaceutical preparations into the bloodstream over time and replacement parts thereof, namely, reusable or disposable medical pump intended to cooperate with medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/07/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/07/2024
FIMP
FINAL DISPOSITION PROCESSED
08/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
27/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/11/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2023
RFNT
REFUSAL PROCESSED BY IB
19/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/03/2023
RFRR
REFUSAL PROCESSED BY MPU
30/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2023
CNRT
NON-FINAL ACTION WRITTEN
07/02/2023
DOCK
ASSIGNED TO EXAMINER
30/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYMBIOZE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.